Cesar O. Freytes, M.D.
Associate Professor,
Division of Hematology
Director, Bone Marrow Transplant Program
|
Location: |
DTL, Room 5.035R |
|
E-mail: |
Research Interests:
Unique Technical and Clinical Research Capabilities/Instrumentation:
We have access to a wide variety of hematologic malignancies. Our lab is capable of doing hematopoietic stem cell cultures, cryo-preservation, and positive selection of hematopoietic stem cells.
Publications:
Freytes C, Pasquini R: Transplante de MÈdula ²sea en el Tratamiento de las Leucemias Agudas in "ActualizaciÛn en Leucemias," Ruiz-Arguelles GJ and San-Miguel JF (editors) Chapter 8 pp. 71-78 Editoral Medica Panamericana, MÈxico, 1996.
Freytes C, Montserrat E: Transplante de MÈdula ²sea en el Tratamiento de las Leucemias CrÛnicas in "ActualizaciÛn en Leucemias," Ruiz-Arguelles GJ and San-Miguel JF (editors) Chapter 16 pp. 121-125 Editorial Medica Panamericana, MÈxico, 1996.
Freytes CO and Beatty PG: Representation of Hispanics in the National Marrow Doner Program. Bone Marrow Transplantation, 1996, 17:323-327.
Tsai T, Freytes CO: "Allogeneic Bone Marrow Transplantation for Leukemias and Aplastic Anemia" in Advances in Internal Medicine, Volume 42, pp. 423-451, Mosby-Year Book, Inc., 1997.
Tsai TW, Hammond LA, Rinaldi M, Martin K, Tio F, Maples J, Freytes CO, Roodman GD: Cokeromyces recurvatus-Induced Diarrhea Following Allogenic Bone Marrow Transplantation. Bone Marrow Transplantation 1997, 19:301-302.
Antman KH, Rawlings PA, Vaughn WP, Pelz CJ, Fay JW, Fields KK, Freytes CO, Gale RP, Hillner B, Holland HK, Kennedy MJ, Klein JP, Lazaruz HM, McCarthy PL, Saez R. Spitzer GL, Stadtmauer EA, Williams SF, Wolff S, Sobocinski KA, Armitage JO, Horowitz MM: High-Dose Chemotherapy with Autologous Hematopoietic Stem-Cell Support for Breast Cancer in North America. J Clin Oncol 1997, 15:1870-1879.
Freytes CO: Vascular Access Devices in Cancer Patients. Toward the Next Step. (Editorial). European Journal of Cancer. In Press.
Freytes CO: Vascular Access Problems Revisited: The Multinationl Association for Supportive Care in Cancer (MASCC) Experience. Supportive Care in Cancer. In Press.
Tsai T, Goodman S, Saez R, Schiller G, Adkins D, Callander N, Wolff S, Freytes CO: Allogenic Bone Marrow Transplantation in Patients Who Relapse Antologous Stem Cell Transplantation. Bone Marrow Transplantation. In Press.
Key Words:
Hematopoietic stem cell transplantation, high dose chemotherapy, experimental chemotherapy